Hero Motors consol PAT up 62% YoY to ₹18 Cr as NPM rebounds to 4.9%, beats preview

Hero Motors' second quarter as a listed company shows a sharp recovery from the margin-credibility scare of its IPO-quarter debut. Consolidated PAT (net profit for the period, before minority split) came in at ₹18.02 Cr, up 62.3% YoY (₹11.10 Cr) and 88.3% QoQ (₹9.57 Cr), on consolidated revenue of ₹364.79 Cr, up 21.3% YoY and 14.2% QoQ. There is no public analyst consensus for this stock — thin post-IPO coverage per our own pre-result preview — so the print cannot be graded against Street numbers; measured against our own pre-result watch (revenue ~₹325 Cr, PAT ₹12-15 Cr), the quarter cleared both markers. Management has issued no formal guidance or outlook on record, and this filing carries no separate press release or MD&A commentary beyond the regulatory outcome letter — so there is nothing from management to grade the print against either. The margin story is the real headline: consolidated NPM recovered to 4.87% from 3.62% a year ago and 2.97% last quarter (the figure that spooked the Street after the debut print), while segment-level operating margin (segment result/revenue) rose to 9.44% from 9.07% YoY and 8.38% QoQ. Both segments grew — Powertrain Solutions revenue +21.4% YoY to ₹197.8 Cr with its segment profit nearly doubling (+68.0% YoY) to ₹28.4 Cr, and Alloys & Metallics revenue +23.6% YoY to ₹186.0 Cr with segment profit +22.3% to ₹11.0 Cr — so the margin recovery is broad-based rather than a single-segment mix shift. Basis note: standalone (parent-only) PAT of ₹23.75 Cr, up 48.8% YoY, is materially ahead of the consolidated figure and grew slower YoY (48.8% vs 62.3%) because six subsidiaries (including the Thai unit) together lost ₹4.53 Cr this quarter versus a smaller drag a year ago — readers comparing the two PAT numbers elsewhere should expect this gap. On corporate activity, the Board approved a fresh investment of up to ₹14 Cr in wholly-owned Hero Motors Thai Ltd (equity and/or loan) to fund its ongoing business, continuing the inorganic/subsidiary-funding push flagged in the IPO prospectus; separately, a CARE Ratings report tracked utilisation of the ₹561.99 Cr allocated net IPO proceeds, of which only ₹216.84 Cr has been deployed so far (₹189.84 Cr debt repayment, ₹27 Cr toward inorganic growth), leaving ₹345.15 Cr still unutilised and parked in deposits/bank balances — this shows up on the balance sheet as a large jump in bank balances and investments. Equity capital also rose to ₹454.22 Cr (from ₹358.34 Cr) on the IPO issue, CCPS conversion (2.10 Cr shares) and ESOP exercises, diluting per-share metrics even as absolute profit grew.